Initial applications for unemployment benefits dropped more than expected to lift the markets to a higher open with
the
Dow rising 23 points to 12,325. Nasdaq climbed 15 points to
2779.
On the upside
Boston Scientific (NYSE: BSX) reported higher second quarter earnings that topped analyst estimates prompting the medical device maker to lift its full year guidance.
The Food and Drug Administration confirmed that Dynavax (Nasdaq: DVAX) achieved clinical consistency in a Phase 3 trial of its hepatitis B vaccine HEPLISAV.
Second quarter earnings surged for LSI (NYSE: LSI) to beat analyst expectations and the company forecast third quarter revenue ahead of estimates prompting an upgrade.
Sprint Nextel (NYSE: S) widened second quarter losses more than expected as the wireless communications company lost monthly contract subscribers.
Alcatel-Lucent (NYSE: ALU) reversed year ago losses but revenue fell short of analyst expectations.
Interpublic Group (NYSE: IPG) reported higher second quarter earnings but the results missed expectations.